Discovery of biomarker evidence in Castleman Disease exemplifies the value of personalized medicine in rare diseases The Castleman Disease Collaborative Network presented new research supported by Medidata at 60th Annual Meeting of the American Society of Hematology Application of Medidata Rave
Rave Engage Named Top Technology for Sponsors at 14th Annual Scrip Awards Medidata Wins Prestigious Industry Award for Third Consecutive Year Scrip Award Celebrates Innovation and Excellence in Biopharmaceutical Industry NEW YORK --(BUSINESS WIRE)--Nov.
NEW YORK --(BUSINESS WIRE)--Nov. 29, 2018-- The United States District Court for the Southern District of New York has rejected Veeva’s motion to dismiss Medidata’s complaint against Veeva for theft of trade secrets, the company announced today. “The Court’s decision allows us to continue with our
NEW YORK --(BUSINESS WIRE)--Nov. 21, 2018-- Medidata (NASDAQ:MDSO) today announced its participation in two upcoming investor conferences. Rouven Bergmann , chief financial officer, will present at the 30th Annual Piper Jaffray Healthcare Conference on Wednesday, Nov.
Medidata Rave Omics Machine Learning Identifies New Evidence of Biomarkers in Rare Disease Research by the Castleman Disease Collaborative Network Memorial Sloan Kettering Cancer Center (MSK) Monitors Newly Diagnosed Myeloma Patients with Medidata ePRO NEW YORK --(BUSINESS WIRE)--Nov.
Leading Sponsor in China to Deliver Innovative Therapies to Patients Worldwide with Medidata Cloud News summary: Hengrui adds Medidata Rave EDC, RTSM, Coder, Safety Gateway and Edge CTMS to support emerging market strategy Medidata Cloud enables unified data management for global clinical trial
SHYFT’s leading platform to become PAREXEL’s foundation for outcomes analysis in support of clinical development and commercialization WALTHAM, Mass. --(BUSINESS WIRE)--Nov. 8, 2018-- SHYFT Analytics, a Medidata Solutions (NASDAQ:MDSO) company, and PAREXEL International , a leading innovator of
French biopharmaceutical company aims to improve data access, quality, and workflow efficiencies Expansion agreement builds upon success in use of Rave EDC Company developing therapies for rare forms of cancer and orphan diseases NEW YORK --(BUSINESS WIRE)--Nov.
News Summary Eight winners were recognized for their innovative approaches to addressing key issues in the digital transformation of life science Two-day hackathon also conducted, aimed at improving patient diversity in clinical trials Awards conclude Medidata NEXT NYC, attended by over 1,000 life
CRO accelerates the delivery of life-changing therapies with a single view of data for all clinical trial stakeholders Pharm-Olam unifies operational systems supporting study execution Global CRO optimizes clinical trial outcomes with Medidata’s artificial intelligence and machine learning Customer